Multidisciplinary approach to Treating Pediatric Obesity with Use of Anti-Obesity Medications


*** Please note this program was a part of the MOA 's 2025 Midwinter Symposium. You will not want to choose this program if you completed this individual program as part of the MOA 2025 Midwinter Symposium. ***

Objectives:

1. Outline Current Prevalence of Pediatric Obesity
2. Review current guidelines and recommendations for the child, adolescent, and young adult with
obesity
3. Review use of current therapies, focusing on anti-obesity medications, recent clinical trials and
what's in the pipeline

This session is accredited for a maximum of  .75 AOA Category 1-A credits. Credits commensurate with participation in the session will be awarded.

MOA Grievance Policy: All grievances should be initially directed in writing to the MOA Executive Director by email to info@mainedo.org who will share them with the MOA's Program Committee. Grievances will receive a response within 30 days of receipt. If you do not receive a satisfactory response, you may notify the Council on Continuing Medical Education, AOA, 142 East Ontario St., Chicago, IL 60611.